#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4406723	A	Inhibition of human recombinant carbonic anhydrase 1 preincubated with enzyme for 1 hr prior to testing by phenol red-based stopped-flow CO2 hydration assay	Homo sapiens	23		single protein format	Scientific Literature
2.	ALA4406724	B	Inhibition of human recombinant carbonic anhydrase 2 preincubated with enzyme for 1 hr prior to testing by phenol red-based stopped-flow CO2 hydration assay	Homo sapiens	23		single protein format	Scientific Literature
3.	ALA4406725	A	Inhibition of human recombinant carbonic anhydrase 4 preincubated with enzyme for 1 hr prior to testing by phenol red-based stopped-flow CO2 hydration assay	Homo sapiens	23		single protein format	Scientific Literature
4.	ALA4406726	A	Inhibition of human recombinant carbonic anhydrase 5A preincubated with enzyme for 1 hr prior to testing by phenol red-based stopped-flow CO2 hydration assay	Homo sapiens	23		single protein format	Scientific Literature
5.	ALA4406727	A	Inhibition of human recombinant carbonic anhydrase 5B preincubated with enzyme for 1 hr prior to testing by phenol red-based stopped-flow CO2 hydration assay	Homo sapiens	23		single protein format	Scientific Literature
6.	ALA4406728	B	Inhibition of human recombinant carbonic anhydrase 7 preincubated with enzyme for 1 hr prior to testing by phenol red-based stopped-flow CO2 hydration assay	Homo sapiens	23		single protein format	Scientific Literature
7.	ALA4406729	A	Inhibition of human recombinant carbonic anhydrase 9 preincubated with enzyme for 1 hr prior to testing by phenol red-based stopped-flow CO2 hydration assay	Homo sapiens	23		single protein format	Scientific Literature
8.	ALA4406730	A	Inhibition of human recombinant carbonic anhydrase 12 preincubated with enzyme for 1 hr prior to testing by phenol red-based stopped-flow CO2 hydration assay	Homo sapiens	23		single protein format	Scientific Literature
9.	ALA4406741	F	Antinociceptive activity in CD-1 albino mouse model of oxaliplatin-induced neuropathic pain assessed as decrease in pain-related behaviour measured as licking latency at 50 mg/kg, po treated on day 15 post oxaliplatin treatment and measured after 15 to 45 mins post dose by cold plate test	Mus musculus	2		organism-based format	Scientific Literature